Pavan Bhargava1, Carlos Nogueras-Ortiz2, Sol Kim1, Francheska Delgado-Peraza2, Peter A Calabresi1, Dimitrios Kapogiannis3. 1. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 2. Laboratory of Clinical Investigation, National Institutes of Aging, Baltimore, MD, USA. 3. Laboratory of Clinical Investigation, National Institutes of Aging, Baltimore, MD, USA/Biomedical Research Center, National Institute on Aging, National Institute of Health, Baltimore, MD, USA/ Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Abstract
BACKGROUND: Synaptic loss is a feature of multiple sclerosis pathology that can be seen even in normal-appearing gray matter. Opsonization of synapses with complement components may underlie pathologic synapse loss. OBJECTIVE: We sought to determine whether circulating neuronal-enriched and astrocytic-enriched extracellular vesicles (NEVs and AEVs) provide biomarkers reflecting complement-mediated synaptic loss in multiple sclerosis. METHODS: From plasma of 61 people with multiple sclerosis (46 relapsing-remitting multiple sclerosis (RRMS) and 15 progressive MS) and 31 healthy controls, we immunocaptured L1CAM + NEVs and GLAST + AEVs. We measured pre- and post-synaptic proteins synaptopodin and synaptophysin in NEVs and complement components (C1q, C3, C3b/iC3b, C4, C5, C5a, C9, Factor B, and Factor H) in AEVs, total circulating EVs, and neat plasma. RESULTS: We found lower levels of NEV synaptopodin and synaptophysin in MS compared to controls (p < 0.0001 for both). In AEVs, we found higher levels of multiple complement cascade components in people with MS compared to controls; these differences were not noted in total EVs or neat plasma. Strikingly, there were strong inverse correlations between NEV synaptic proteins and multiple AEV complement components in MS, but not in controls. CONCLUSION: Circulating EVs could identify synaptic loss in MS and suggest a link between astrocytic complement production and synaptic loss.
BACKGROUND: Synaptic loss is a feature of multiple sclerosis pathology that can be seen even in normal-appearing gray matter. Opsonization of synapses with complement components may underlie pathologic synapse loss. OBJECTIVE: We sought to determine whether circulating neuronal-enriched and astrocytic-enriched extracellular vesicles (NEVs and AEVs) provide biomarkers reflecting complement-mediated synaptic loss in multiple sclerosis. METHODS: From plasma of 61 people with multiple sclerosis (46 relapsing-remitting multiple sclerosis (RRMS) and 15 progressive MS) and 31 healthy controls, we immunocaptured L1CAM + NEVs and GLAST + AEVs. We measured pre- and post-synaptic proteins synaptopodin and synaptophysin in NEVs and complement components (C1q, C3, C3b/iC3b, C4, C5, C5a, C9, Factor B, and Factor H) in AEVs, total circulating EVs, and neat plasma. RESULTS: We found lower levels of NEV synaptopodin and synaptophysin in MS compared to controls (p < 0.0001 for both). In AEVs, we found higher levels of multiple complement cascade components in people with MS compared to controls; these differences were not noted in total EVs or neat plasma. Strikingly, there were strong inverse correlations between NEV synaptic proteins and multiple AEV complement components in MS, but not in controls. CONCLUSION: Circulating EVs could identify synaptic loss in MS and suggest a link between astrocytic complement production and synaptic loss.
Authors: Edward J Goetzl; Janice B Schwartz; Erin L Abner; Gregory A Jicha; Dimitrios Kapogiannis Journal: Ann Neurol Date: 2018-03-10 Impact factor: 10.422
Authors: Sahil Chawla; Seema Gulyani; Richard P Allen; Christopher J Earley; Xu Li; Peter Van Zijl; Dimitrios Kapogiannis Journal: Sleep Date: 2019-07-08 Impact factor: 5.849
Authors: Edward J Goetzl; Dimitrios Kapogiannis; Janice B Schwartz; Iryna V Lobach; Laura Goetzl; Erin L Abner; Gregory A Jicha; Anna M Karydas; Adam Boxer; Bruce L Miller Journal: FASEB J Date: 2016-09-06 Impact factor: 5.191
Authors: Victoria F Beja-Glasser; Bianca M Nfonoyim; Soyon Hong; Arnaud Frouin; Shaomin Li; Saranya Ramakrishnan; Katherine M Merry; Qiaoqiao Shi; Arnon Rosenthal; Ben A Barres; Cynthia A Lemere; Dennis J Selkoe; Beth Stevens Journal: Science Date: 2016-03-31 Impact factor: 47.728
Authors: Maja Mustapic; Erez Eitan; John K Werner; Sean T Berkowitz; Michael P Lazaropoulos; Joyce Tran; Edward J Goetzl; Dimitrios Kapogiannis Journal: Front Neurosci Date: 2017-05-22 Impact factor: 4.677
Authors: Gillian Ingram; Sam Loveless; Owain W Howell; Svetlana Hakobyan; Bethan Dancey; Claire L Harris; Neil P Robertson; James W Neal; B Paul Morgan Journal: Acta Neuropathol Commun Date: 2014-05-09 Impact factor: 7.801
Authors: Christian W Keller; Johanna Oechtering; Heinz Wiendl; Ludwig Kappos; Jens Kuhle; Jan D Lünemann Journal: Ann Clin Transl Neurol Date: 2021-03-01 Impact factor: 4.511
Authors: Cathryn M Kolka; Julie Webster; Ailin Lepletier; Clay Winterford; Ian Brown; Renee S Richards; Wioleta M Zelek; Yilang Cao; Ramlah Khamis; Karthik B Shanmugasundaram; Alain Wuethrich; Matt Trau; Sandra Brosda; Andrew Barbour; Alok K Shah; Guy D Eslick; Nicholas J Clemons; B Paul Morgan; Michelle M Hill Journal: Front Immunol Date: 2022-03-08 Impact factor: 8.786
Authors: Janine Utz; Judith Berner; Luis Enrique Muñoz; Timo Jan Oberstein; Johannes Kornhuber; Martin Herrmann; Juan Manuel Maler; Philipp Spitzer Journal: Front Aging Neurosci Date: 2021-07-06 Impact factor: 5.750